Patents by Inventor Peter Holst

Peter Holst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VACCINE FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF A DISEASE
    Publication number: 20250186579
    Abstract: A vaccine for use in the prophylaxis and/or treatment of a disease The present invention relates to an adenoviral vector capable of encoding a virus-like particle (VLP), said VLP displaying an inactive immune-suppressive domain (ISD). The vaccine of the invention shows an improved immune response from either of both of the response pathways initiated by CD4 T cells or CD8 T cells.
    Type: Application
    Filed: February 21, 2025
    Publication date: June 12, 2025
    Applicant: INPROTHER APS
    Inventors: Peter HOLST, Christian THIRION, Lasse NEUKIRCH
  • Devices and Methods for Providing a Bolus Dose in a Microfluidic Circuit of a Pump
    Publication number: 20250186690
    Abstract: Devices and methods for administering a medication in fluid form, the systems and methods including a basal flow path and a bolus flow path in parallel to the basal flow path. The bolus flow path comprises a first check valve, a second check valve downstream of the first check valve, a piston pump disposed between the first valve and the second valve, and a pilot operated valve in parallel to the piston pump.
    Type: Application
    Filed: February 20, 2025
    Publication date: June 12, 2025
    Inventors: Hermanus Stephanus Pretorius, Robert Farra, Kenneth Barnett, David Piper, Russell Ford, Edward G. Solomon, Peter Holst, Lawrence Smith
  • Vaccine for use in the prophylaxis and/or treatment of a disease
    Patent number: 12263214
    Abstract: The present invention relates to an adenoviral vector capable of encoding a virus-like particle (VLP), said VLP displaying an inactive immune-suppressive domain (ISD). The vaccine of the invention shows an improved immune response from either of both of the response pathways initiated by CD4 T cells or CD8 T cells.
    Type: Grant
    Filed: January 16, 2024
    Date of Patent: April 1, 2025
    Assignee: INPROTHER APS
    Inventors: Peter Holst, Christian Thirion, Lasse Neukirch
  • Devices and methods for providing a bolus dose in a microfluidic circuit of a pump
    Patent number: 12257417
    Abstract: Devices and methods for administering a medication in fluid form, the systems and methods including a basal flow path and a bolus flow path in parallel to the basal flow path. The bolus flow path includes a combined piston pump and rotatable valve. The piston pump is configured to prevent partial dosing of a bolus dose.
    Type: Grant
    Filed: April 15, 2021
    Date of Patent: March 25, 2025
    Assignee: CEQUR SA
    Inventors: Hermanus Stephanus Pretorius, Robert Farra, Kenneth Barnett, David Piper, Russell Ford, Edward G. Solomon, Peter Holst, Lawrence Smith
  • HANDHELD MEDICAL DEVICE WITH IMPROVED DELIVERY OF AEROSOL PARTICLES
    Publication number: 20240408325
    Abstract: A handheld medical device with internal structures to improve the delivery of aerosol particles and its uses. The structures include airflow diverting structures, airflow straightening structures and/or internal walls defining an angle.
    Type: Application
    Filed: June 14, 2024
    Publication date: December 12, 2024
    Applicant: ALEXZA PHARMACEUTICALS, INC.
    Inventors: David Koji HASEGAWA, Peter HOLST, Dmitriy PETROVYKH
  • DAMPED AUTOINJECTORS
    Publication number: 20240316287
    Abstract: Autoinjectors comprising an energy source mechanism, a damping mechanism and a delivery mechanism with a formulation that is to be delivered to a subject in need thereof are described. Also described are damping mechanisms that, in addition to other advantages, reduce the initial force and pressure spikes when energy is released from the energy source.
    Type: Application
    Filed: December 27, 2021
    Publication date: September 26, 2024
    Inventors: Peter Holst, Samuel Sayre, Alec Lindeman
  • Vaccine for use in the prophylaxis and/or treatment of a disease
    Patent number: 12023377
    Abstract: The present invention relates to an adenoviral vector capable of encoding a virus-like particle (VLP), said VLP displaying an inactive immune-suppressive domain (ISD). The vaccine of the invention shows an improved immune response from either of both of the response pathways initiated by CD4 T cells or CD8 T cells.
    Type: Grant
    Filed: April 28, 2022
    Date of Patent: July 2, 2024
    Assignee: INPROTHER APS
    Inventors: Peter Holst, Christian Thirion, Lasse Neukirch
  • CAP FOR USE WITH VARIETY OF INJECTION PENS AND RELATED DEVICES AND METHODS
    Publication number: 20240207532
    Abstract: A cap for use with a variety of injection pens includes one or more adaptable elements. The one or more adaptable elements may be configured to removably couple the pen cap to a plurality of different geometries of a plurality of different injection pens.
    Type: Application
    Filed: December 27, 2023
    Publication date: June 27, 2024
    Inventors: Michael J. Wakim, Olga Smelyanets, Christopher Kovalchick, Rachael Price, Aaron Townsend, Peter Holst, Liam Parrish, Alex Martinez, Alec Lindeman, Samue Sayre
  • VACCINE FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF A DISEASE
    Publication number: 20240148860
    Abstract: The present invention relates to an adenoviral vector capable of encoding a virus-like particle (VLP), said VLP displaying an inactive immune-suppressive domain (ISD). The vaccine of the invention shows an improved immune response from either of both of the response pathways initiated by CD4 T cells or CD8 T cells.
    Type: Application
    Filed: January 16, 2024
    Publication date: May 9, 2024
    Applicant: INPROTHER APS
    Inventors: Peter HOLST, Christian THIRION, Lasse NEUKIRCH
  • Vaccine for use in the prophylaxis and/or treatment of a disease
    Patent number: 11883487
    Abstract: The present invention relates to an adenoviral vector capable of encoding a virus-like particle (VLP), said VLP displaying an inactive immune-suppressive domain (ISD). The vaccine of the invention shows an improved immune response from either of both of the response pathways initiated by CD4 T cells or CD8 T cells.
    Type: Grant
    Filed: April 28, 2022
    Date of Patent: January 30, 2024
    Assignee: INPROTHER APS
    Inventors: Peter Holst, Christian Thirion, Lasse Neukirch
  • A VACCINE FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF A DISEASE
    Publication number: 20230181716
    Abstract: The present invention relates to an adenoviral vector capable of encoding a virus-like particle (VLP), said VLP displaying an inactive immune-suppressive domain (ISD). The vaccine of the invention shows an improved immune response from either of both of the response pathways initiated by CD4 T cells or CD8 T cells.
    Type: Application
    Filed: August 30, 2019
    Publication date: June 15, 2023
    Applicant: INPROTHER APS
    Inventors: Peter HOLST, Christian THIRION, Lasse NEUKIRCH
  • VACCINE FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF A DISEASE
    Publication number: 20220387580
    Abstract: The present invention relates to an adenoviral vector capable of encoding a virus-like particle (VLP), said VLP displaying an inactive immune-suppressive domain (ISD). The vaccine of the invention shows an improved immune response from either of both of the response pathways initiated by CD4 T cells or CD8 T cells.
    Type: Application
    Filed: April 28, 2022
    Publication date: December 8, 2022
    Applicant: INPROTHER APS
    Inventors: Peter HOLST, Christian THIRION, Lasse NEUKIRCH
  • VACCINE FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF A DISEASE
    Publication number: 20220347291
    Abstract: The present invention relates to an adenoviral vector capable of encoding a virus-like particle (VLP), said VLP displaying an inactive immune-suppressive domain (ISD). The vaccine of the invention shows an improved immune response from either of both of the response pathways initiated by CD4 T cells or CD8 T cells.
    Type: Application
    Filed: April 28, 2022
    Publication date: November 3, 2022
    Applicant: INPROTHER APS
    Inventors: Peter HOLST, Christian THIRION, Lasse NEUKIRCH
  • Vaccine for use in the prophylaxis and/or treatment of a disease
    Patent number: 11351247
    Abstract: The present invention relates to an adenoviral vector capable of encoding a virus-like particle (VLP), said VLP displaying an inactive immune-suppressive domain (ISD). The vaccine of the invention shows an improved immune response from either of both of the response pathways initiated by CD4 T cells or CD8 T cells.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: June 7, 2022
    Assignee: INPROTHER APS
    Inventors: Peter Holst, Christian Thirion, Lasse Neukirch
  • DEVICES AND METHODS FOR PROVIDING A BOLUS DOSE IN A MICROFLUIDIC CIRCUIT OF A PUMP
    Publication number: 20210228801
    Abstract: Devices and methods for administering a medication in fluid form, the systems and methods including a basal flow path and a bolus flow path in parallel to the basal flow path. The bolus flow path includes a combined piston pump and rotatable valve. The piston pump is configured to prevent partial dosing of a bolus dose.
    Type: Application
    Filed: April 15, 2021
    Publication date: July 29, 2021
    Inventors: Hermanus Stephanus Pretorius, Robert Farra, Kenneth Barnett, David Piper, Russell Ford, Edward G. Solomon, Peter Holst, Lawrence Smith
  • Devices and methods for providing a bolus dose in a microfluidic circuit of a pump
    Patent number: 11007317
    Abstract: Devices and methods for administering a medication in fluid form, the systems and methods including a basal flow path and a bolus flow path in parallel to the basal flow path. The bolus flow path includes an inlet check valve, a first outlet check valve downstream of the inlet check valve, and a piston pump disposed between the inlet check valve and the first outlet check valve. The piston pump is configured to prevent partial dosing of a bolus dose.
    Type: Grant
    Filed: May 2, 2019
    Date of Patent: May 18, 2021
    Assignee: CEQUR SA
    Inventors: Hermanus Stephanus Pretorius, Robert Farra, Kenneth Barnett, David Piper, Russell Ford, Edward G. Solomon, Peter Holst, Lawrence Smith
  • A VACCINE FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF A DISEASE
    Publication number: 20200330586
    Abstract: The present invention relates to an adenoviral vector capable of encoding a virus-like particle (VLP), said VLP displaying an inactive immune-suppressive domain (ISD). The vaccine of the invention shows an improved immune response from either of both of the response pathways initiated by CD4 T cells or CD8 T cells.
    Type: Application
    Filed: August 30, 2018
    Publication date: October 22, 2020
    Applicant: INPROTHER APS
    Inventors: Peter HOLST, Christian THIRION, Lasse NEUKIRCH
  • DEVICES AND METHODS FOR PROVIDING A BOLUS DOSE IN A MICROFLUIDIC CIRCUIT OF A PUMP
    Publication number: 20190336680
    Abstract: Devices and methods for administering a medication in fluid form, the systems and methods including a basal flow path and a bolus flow path in parallel to the basal flow path. The bolus flow path includes an inlet check valve, a first outlet check valve downstream of the inlet check valve, and a piston pump disposed between the inlet check valve and the first outlet check valve. The piston pump is configured to prevent partial dosing of a bolus dose.
    Type: Application
    Filed: May 2, 2019
    Publication date: November 7, 2019
    Inventors: Hermanus Stephanus Pretorius, Robert Farra, Kenneth Barnett, David Piper, Russell Ford, Edward G. Solomon, Peter Holst, Lawrence Smith
  • Multi focal spot collimator
    Patent number: 9257207
    Abstract: An x-ray collimator can be constructed from multiple subassemblies, which at least includes a first subassembly that reduces the leakage of x-ray radiation between adjacent apertures and a second subassembly that reduces the spill of x-ray radiation around the detector face. Each of these subassemblies has numerous apertures. In the first subassembly these apertures correspond to focal spots on an x-ray source, and in the second subassembly, these apertures are shaped such that the dimensions increase from smaller entrances to larger exits.
    Type: Grant
    Filed: November 8, 2011
    Date of Patent: February 9, 2016
    Assignee: Triple Ring Technologies, Inc.
    Inventors: Tobias Funk, Brian Wilfley, Peter Holst
  • MULTI FOCAL SPOT COLLIMATOR
    Publication number: 20130114796
    Abstract: An x-ray collimator can be constructed from multiple subassemblies, which at least includes a first subassembly that reduces the leakage of x-ray radiation between adjacent apertures and a second subassembly that reduces the spill of x-ray radiation around the detector face. Each of these subassemblies has numerous apertures. In the first subassembly these apertures correspond to focal spots on an x-ray source, and in the second subassembly, these apertures are shaped such that the dimensions increase from smaller entrances to larger exits.
    Type: Application
    Filed: November 8, 2011
    Publication date: May 9, 2013
    Inventors: TOBIAS FUNK, BRIAN WILFLEY, PETER HOLST